OLUMIANT 2 TABLET contains Baricitinib which belongs to the group of medicines called Janus kinase inhibitors. OLUMIANT 2 TABLET is used to manage adults with moderate to severe rheumatoid arthritis (inflammatory disease of the joints), who have responded inadequately to, or who are intolerant to previous therapies. OLUMIANT 2 TABLET is also used to manage adults with moderate to severe atopic dermatitis (atopic eczema).
Prior to the management, your doctor may want you to take several blood tests to understand your existing condition like low red blood cell count (anaemia), low white blood cell count (neutropenia or lymphopenia), high cholesterol levels or high levels of liver enzymes, to ensure that management with OLUMIANT 2 TABLET is not causing problems. Along with this, your doctor may test you for TB before starting management with OLUMIANT 2 TABLET.
OLUMIANT 2 TABLET is not recommended for use in patients having liver, kidney, heart diseases, stroke, and active infections like Tuberculosis. You will not be given certain live vaccines while using OLUMIANT 2 TABLET.
Inform your doctor if you have diabetes, chronic lung disease, low red blood cells, HIV, or a weak immune system. Infections like tuberculosis, multidermatomal herpes zoster, esophageal candidiasis, pneumocystosis, acute histoplasmosis, cryptococcosis, cytomegalovirus, and BK virus or if you often get infections.
OLUMIANT 2 TABLET is not recommended for use in pregnant and breast feeding. Consult your doctor before taking. OLUMIANT 2 TABLET is not recommended for use in children and adolescents under 18 years of age and should be used with caution in elderly patients above 75 years of age.
The most common side effects of taking OLUMIANT 2 TABLET are signs of cold sores, shingles (painful skin rash with blisters) and infections of the throat, nose (cold, sinus) stomach (gastroenteritis), lungs (pneumonia), urinary tract infections, headache, nausea, stomach pain, high levels of blood...
No content available
